--2025/Q2-- / 419.800M--
--2024/Q4-- / 390.800M--
--2023/Q2120.700M / ----
--2022/Q480.749M / 68.850M--
--2022/Q355.300M / ----
US Stock MarketDetailed Quotes
TLX Telix Pharmaceuticals
- 16.010
- +0.010+0.06%
Close Dec 18 16:00 ET
5.36BMarket Cap184.02P/E (TTM)
17.960High15.858Low10.61KVolume16.000Open16.000Pre Close173.52KTurnover0.06%Turnover Ratio1778.89P/E (Static)334.72MShares19.99052wk High22.42P/B272.17MFloat Cap14.44052wk Low--Dividend TTM17.00MShs Float19.990Historical High--Div YieldTTM13.14%Amplitude14.440Historical Low16.350Avg Price1Lot Size
Telix Pharmaceuticals Key Stats
Telix Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: AUD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Heat List
US
Overall
Symbol
Price
% Chg
No Data
